Clinical Trial Update: Assess the Safety and Tolerability of SNS851 in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety and tolerability of SNS851 in healthy participants; recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Disease

Drugs mentioned

• SNS851

Snippet

Sponsor: Oneness Biotech Co., Ltd. | Conditions: Metabolic Disease | Phase 1 | Status: RECRUITING